cetylpyridinium chloride anhydrous has been researched along with Body Weight, Fetal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balmaceda, Ydel V; Barrientos, E; Berlingueres, S; Calvo, EB; Cámera, K; Garciarena, S; González, C; López, LB; Poy, MS; Quintana, L | 1 |
Laskowska, K; Laskowska, M; Oleszczuk, J | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Body Weight, Fetal
Article | Year |
---|---|
Reference charts for weight gain and body mass index during pregnancy obtained from a healthy cohort.
Topics: Adult; Argentina; Body Height; Body Mass Index; Cohort Studies; Female; Fetal Development; Fetal Weight; Health; Humans; Infant, Newborn; Longitudinal Studies; Middle Aged; Pregnancy; Reference Values; Weight Gain; Young Adult | 2009 |
Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
Topics: Adult; Antigens, CD; Biomarkers; Birth Weight; Case-Control Studies; Endoglin; Female; Fetal Growth Retardation; Fetal Weight; Gestational Age; Health; Humans; Infant, Low Birth Weight; Infant, Newborn; Osmolar Concentration; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnant Women; Receptors, Cell Surface; Young Adult | 2012 |